CBD is the abbreviation of the term “cannabidiol”. This molecule is one of the many cannabinoids present in hemp.

Unlike the plant's best-known active ingredient, delta-9-tetrahydrocannabinol (THC),

CBD “is ​​another hemp molecule which does not have a narcotic effect”.

The cannabinoid, otherwise known as CBD, was first discovered around the year 1940. It was extracted from hemp and studied for its pharmacological properties. In particular, it has been attributed benefits against nausea and inflammation.

Later, researchers discovered that this molecule could help slow the degeneration of nerve cells.

However, CBD oil, CBD resin – such as Pollen or other dosage forms of this product – and others are not medicines.

These products do not cure, but greatly help relieve symptoms.

CBD is considered a dietary supplement and not a medicine.

As mentioned above, THC and CBD are the two most important cannabinoids found in all varieties of hemp.

However there is a fundamental difference. Tetrahydrocannabinol THC causes psychotropic effects, feelings of intoxication, euphoria, etc.

In short, it is the molecule responsible for the “high” state in which we find ourselves when we consume hemp.

As for the effects of CBD, they do not cause a change in state of mind and it is mainly consumed for its soothing and anti-inflammatory properties.

Another difference between these two cannabinoids is that they are extracted from two different varieties of hemp.

CBD is generally produced from hemp which contains a high percentage of CBD and almost no tetrahydrocannabinol (less than 0.2% THC).

Tetrahydrocannabinol is generally extracted from marijuana which contains a high percentage, on average between 10 and 30%.

The legislative framework for CBD is indirectly set by the laws concerning hemp and tetrahydrocannabinol.

European legislation therefore authorizes hemp, and therefore cannabidiol, provided that it does not exceed a maximum level of tetrahydrocannabinol set at 0.2%. The sale and purchase of cannabidiol is therefore legal in most European countries.

In France The production, sale and consumption of CBD are in fact regulated by legislation concerning the hemp from which it is extracted.

The use of CBD is authorized when the plant does not have reprehensible narcotic properties, in other words when the tetrahydrocannabinol content of the plant before processing is less than 0.2%.

CBD cannabidiol does not have psychoactive effects.

The effects of CBD on the body and mind are numerous and are generally very positive.

You should know that our body has a system capable of regulating vital biological functions such as sleep, appetite, mood, sensitivity to pain.

As a result, CBD activates the CB1 and CB2 receptors which are themselves connected to the central nervous system.

Here are some Effects of CBD:

Anxyolitic, Anti-stress, Anti-oxidant, Anti-inflammatory, Anti-epileptic

Anti-emetic, Anti-depressive, Antipsychotic, Sedative, Neuroprotective

Painkillers, would help to improve the quality of sleep in people with insomnia, would reduce seizures in patients with schizophrenia, would be effective against osteoarthritis pain and contractures, relieves neuropathic pain, helps fight against dependence on drugs and alcohol and research all over the world is underway which allows us to find new benefits of CBD every day.

In France, we are not authorized to provide information on the benefits and therapeutic properties of our products. Our products are not intended for the cure of diseases, nor for the prevention of them. Consult your doctor before consuming CBD. Please use the products in accordance with their recommended usage. NO SMOKING. Consult your doctor if you have health problems.

To obtain CBD in France, it is advisable to turn to serious and reliable producers: the products must be analyzed and controlled to prove their content, while respecting the European and French standards in force.

The products offered by madehellin.com are among the best in Europe.